0:000:00
<p>FDA approves triple-drug polypill, a change of opinion, a deep dive into invasive pulmonary embolism therapies, heart disease trends, and diabetes care is on fire are the topics John Mandrola, MD, discusses in this week's podcast.</p> <p><em>This podcast is intended for healthcare professionals only</em>.</p> <p>To read a partial transcript or to comment, visit:</p> <p>https://www.medscape.com/twic</p> <p><strong>I FDA News in HTN</strong></p> <ul> <li><strong>FDA announcement https://george-medicines.com/george-medicines-announces-fda-approval-of-widaplik-telmisartan-amlodipine-and-indapamide-a-new-single-pill-combination-treatment-for-hypertension-in-adults-including-initial-treatment/</strong></li> <li><strong>Lancet Study https://doi.org/10.1016/S0140-6736(24)01744-6</strong></li> <li><strong>JACC study vs placebo https://www.jacc.org/doi/abs/10.1016/j.jacc.2024.08.025</strong></li> <li><strong>JAMA Cardiology Meta-analysis https://jamanetwork.com/journals/jamacardiology/fullart...